1Suppliers
5Customers
3Debt Items
12Related Chains

Source-Backed Evidence Depth

ClearPoint Neuro, Inc. (CLPT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
1Distinct source URLs
6High confidence
0.800Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

ClearPoint Neuro, Inc. Suppliers

TickerNameConfidenceEvidence
PTCT PTC Therapeutics, Inc. 72% Reciprocal relationship from PTCT graph: Reciprocal relationship from CLPT graph: Reciprocal relationship from PTCT graph: or its PTC-AADC indefinite-lived intangible asset as of October 1, 2024 and …

ClearPoint Neuro, Inc. Customers

TickerNameConfidenceEvidence
PHARMACEUTICAL-CUSTOMER PHARMACEUTICAL-CUSTOMER 92% One pharmaceutical customer, a related party who is a former stockholder and former noteholder, and whose chief executive officer is a member of the Company's Board of Directors, for whom the Company…
ONE-ADDITIONAL-CUSTOMER ONE-ADDITIONAL-CUSTOMER 90% There was one additional customer who accounted for 11 % of the total sales for the three months ended March 31, 2025
CALW-SA-LLC CALW-SA-LLC 62% ntangible Assets Goodwill A summary of the activity impacting goodwill is presented below (in thousands): Balance as of December 31, 2025 $ 7,472 Measurement period adjustments — Balance as of March …
IRRAS-HOLDINGS-INC IRRAS-HOLDINGS-INC 62% of the Company's ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses and future expectations. The Company is subject to risks common to emerging compan…
OBERLAND-CAPITAL-MANAGEMENT-LLC OBERLAND-CAPITAL-MANAGEMENT-LLC 62% ntangible Assets Goodwill A summary of the activity impacting goodwill is presented below (in thousands): Balance as of December 31, 2025 $ 7,472 Measurement period adjustments — Balance as of March …

ClearPoint Neuro, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CLPT-DEBT Debt stack $822,015 90% Market cache reports total debt of $822,015.
CLPT-DEBT-8695 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
CLPT-DEBT-8694 Warrants outstanding: 1300000 90% xbrl warrant detail from xbrl 2019-12-31.

ClearPoint Neuro, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ClearPoint Neuro, Inc..

ClearPoint Neuro, Inc. Ownership

HolderNameConfidenceEvidence
CLPT-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 123 tracked holders.

ClearPoint Neuro, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LXEO Lexeo Therapeutics, Inc. 100.00 2
TRDA Entrada Therapeutics, Inc. 100.00 2
RNA Atrium Therapeutics, Inc. 100.00 2
ROCHE ROCHE 100.00 2
KROS Keros Therapeutics, Inc. 50.00 2
RGNX REGENXBIO Inc. 50.00 2
AKCEA AKCEA 50.00 2
PTCT PTC Therapeutics, Inc. 36.29 1 ['supplier']
RPI RPI 24.13 2
NVSEF Novartis AG 14.78 2
RPRX Royalty Pharma plc 14.78 2
IONS Ionis Pharmaceuticals, Inc. 14.78 2
🔐
CLPT
Unlock CLPT Supply Chain Data
Verified relationships include:
PTCTPTC Therapeutics, Inc.Supplier72%
PHARMACEUTICAL-CUSTOMERPHARMACEUTICAL-CUSTOMERCustomer92%
ONE-ADDITIONAL-CUSTOMERONE-ADDITIONAL-CUSTOMERCustomer90%
+6 more relationships locked
Subscribe — View plans →